0 211

Cited 0 times in

Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev

DC Field Value Language
dc.contributor.author백순명-
dc.date.accessioned2023-06-02T00:43:04Z-
dc.date.available2023-06-02T00:43:04Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194367-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleAssociation of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentBioMedical Science Institute (의생명과학부)-
dc.contributor.googleauthorKatherine L. Pogue-Geile-
dc.contributor.googleauthorMarion E Joy-
dc.contributor.googleauthorYing Wang-
dc.contributor.googleauthorRim S Kim-
dc.contributor.googleauthorPatrick G Gavin-
dc.contributor.googleauthorDebora Fumagalli-
dc.contributor.googleauthorGreg Yothers-
dc.contributor.googleauthorCarmen Joseph Allegra-
dc.contributor.googleauthorAshok Srinivasan-
dc.contributor.googleauthorMelanie Finnigan-
dc.contributor.googleauthorSamuel A. Jacobs-
dc.contributor.googleauthorThomas J. George-
dc.contributor.googleauthorJennifer Marie Suga-
dc.contributor.googleauthorJudith O. Hopkins-
dc.contributor.googleauthorNaoyuki G. Saito-
dc.contributor.googleauthorNorman Wolmark-
dc.contributor.googleauthorSoonmyung Paik-
dc.contributor.googleauthorPeter C. Lucas-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.140-
dc.contributor.localIdA01823-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.140-
dc.contributor.alternativeNamePaik, Soon Myung-
dc.contributor.affiliatedAuthor백순명-
dc.citation.volume40-
dc.citation.number4 suppl-
dc.citation.startPage140-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 140, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > BioMedical Science Institute (의생명과학부) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.